Hoppichler F, Kraft H G, Sandholzer C, Lechleitner M, Patsch J R, Utermann G
Department of Internal Medicine, University Hospital Innsbruck, Austria.
Atherosclerosis. 1996 Apr 26;122(1):127-34. doi: 10.1016/0021-9150(96)05803-0.
Association of apo(a)/Lp(a) with triglyceride-rich lipoproteins (TGR-Lps) is determined by different factors that are poorly understood. Some previous studies suggested that apo(a) in TGR-Lps may affect the atherogenicity of the TGR particles. To study whether there are any peculiarities in postprandial (pp) Lp(a) metabolism, we have determined apo(a) phenotypes and Lp(a) concentrations in 46 subjects with coronary heart disease (CHD) and in six normolipidemic individuals at different time points (4, 6 and 8 h) following an oral fat tolerance test. While mean triglyceride concentration reached its maximum 6 h after a standardized fat meal, no change in total cholesterol and in mean Lp(a) plasma concentration was detected at any time point after the fat load. In 6 normolipidemic probands and in 8 patients with CHD, who were matched for apo(a) phenotype, lipoprotein levels, age and body weight, we followed the distribution of apo(a) in plasma density gradient fractions in the fasting and pp state. In the CHD patients a significant larger percentage of apo(a) reactivity was detected in TGR-Lps in the pre- as well as in the postprandial state, compared to control subjects. The fat intake did not induce a significant change of apo(a) reactivity in the TGR-Lp fractions in both groups. The apo(a) isoform-size and the Lp(a) plasma concentration in the fasting state had no influence on the individual variation of the Lp(a) concentration in pp TGR-Lp fractions. Our results provide evidence that TGR-Lp fractions of CHD patients are enriched in apo(a) reactivity compared to healthy controls, but do not support the hypothesis that Lp(a) acts atherogenically through a pp increase of its plasma concentration.
载脂蛋白(a)/脂蛋白(a)[apo(a)/Lp(a)]与富含甘油三酯的脂蛋白(TGR-Lps)之间的关联由一些尚未完全了解的不同因素所决定。之前的一些研究表明,TGR-Lps中的载脂蛋白(a)可能会影响TGR颗粒的致动脉粥样硬化性。为了研究餐后(pp)脂蛋白(a)代谢是否存在任何特殊之处,我们测定了46名冠心病(CHD)患者和6名血脂正常个体在口服脂肪耐量试验后不同时间点(4、6和8小时)的载脂蛋白(a)表型和脂蛋白(a)浓度。在一顿标准化脂肪餐后6小时,平均甘油三酯浓度达到最高,但在脂肪负荷后的任何时间点,总胆固醇和血浆脂蛋白(a)平均浓度均未检测到变化。在6名血脂正常的先证者和8名在载脂蛋白(a)表型、脂蛋白水平、年龄和体重方面相匹配的冠心病患者中,我们追踪了空腹和餐后状态下血浆密度梯度组分中载脂蛋白(a)的分布情况。与对照组相比,在冠心病患者中,无论餐前还是餐后状态,TGR-Lps中检测到的载脂蛋白(a)反应性百分比均显著更高。两组中脂肪摄入均未引起TGR-Lp组分中载脂蛋白(a)反应性的显著变化。空腹状态下的载脂蛋白(a)异构体大小和血浆脂蛋白(a)浓度对餐后TGR-Lp组分中脂蛋白(a)浓度的个体差异没有影响。我们的结果表明,与健康对照组相比,冠心病患者的TGR-Lp组分中载脂蛋白(a)反应性更高,但并不支持脂蛋白(a)通过餐后血浆浓度升高而发挥致动脉粥样硬化作用这一假说。